Safety and Efficacy of Adjusted Dose of Rivaroxaban in Japanese Patients With Non-Valvular Atrial Fibrillation-Reference-Cited by-同舟云学术

Safety and Efficacy of Adjusted Dose of Rivaroxaban in Japanese Patients With Non-Valvular Atrial Fibrillation

Published:2013 Issue:3 Volume:77 Page:632-638
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Hori Masatsugu¹,Matsumoto Masayasu²,Tanahashi Norio³,Momomura Shin-ichi⁴,Uchiyama Shinichiro⁵,Goto Shinya⁶,Izumi Tohru⁷,Koretsune Yukihiro⁸,Kajikawa Mariko⁹,Kato Masaharu⁹,Ueda Hitoshi⁹,Iwamoto Kazuya⁹,Tajiri Masahiro⁹,on behalf of the J-ROCKET AF study investigators

Affiliation:

1. Osaka Medical Center for Cancer and Cardiovascular Diseases

2. Department of Clinical Neuroscience and Therapeutics, Hiroshima University

3. Department of Neurology, Saitama Medical University International Medical Center

4. Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University

5. Department of Neurology, Tokyo Women’s Medical University

6. Department of Medicine (Cardiology), Tokai University School of Medicine

7. Department of Cardio-angiology, Kitasato University School of Medicine

8. Institute for Clinical Research, Osaka National Hospital

9. Bayer Yakuhin

Publisher

Japanese Circulation Society